Cancer immunotherapy: The interferon-α experience

This publication has 46 references indexed in Scilit:

• The Emerging Role of Cytokines in the Treatment of Advanced Melanoma
  Oncology, 2000
• Interferon Alpha-2a and 13-cis-Retinoic Acid in Patients with Metastatic Renal Cell Cancer
  Cancer Investigation, 2000
• Combined Subcutaneous Recombinant α–Interferon and Interleukin–2 in Metastatic Renal Cell Cancer: Results of the Multicentre All Ireland Immunotherapy Study Group
  European Urology, 2000
• Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference
  Journal of Gastroenterology and Hepatology, 1999
• Regimens With or Without Interferon-α as Treatment for Metastatic Melanoma and Renal Cell Carcinoma: An Overview of Randomized Trials
  Journal of Immunotherapy, 1999
• Antibodies to Interferon-α in Treated Cancer Patients: Incidence and Significance
  Journal of Interferon & Cytokine Research, 1997
• A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group
  European Journal Of Cancer, 1995
• Adjuvant Therapy of Stage IIIb Melanoma with Interferon Alfa-2b: Clinical and Immunological Relevance
  Dermatology, 1995
• Alpha interferon: The potential drug of adjuvant therapy: Past achievements and future challenges
  European Journal of Cancer and Clinical Oncology, 1991
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986